文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气消化、代谢与肾脏急症

重症组织胞浆菌病死亡相关因素:瓜德罗普与法属圭亚那多中心回顾性研究

Factors related to mortality in critically ill histoplasmosis: a multicenter retrospective study in Guadeloupe and French Guyana.
PubMed 文献 · Ann Intensive Care · 2023-04-21
一句话结论重症组织胞浆菌病需ICU入住者30天死亡率53%,SOFA评分、症状出现至治疗时间及噬血细胞性淋巴组织细胞增生症与30天死亡独立相关。

该多中心回顾性研究纳入法属圭亚那和瓜德罗普两个ICU在2014年1月至2022年8月间收治的40例培养证实的组织胞浆菌病患者(65%男性,中位年龄56岁,SAPS II 65),描述临床生物学特征及结局,并用单因素和多因素分析评估入ICU时与死亡相关的危险因素。入ICU 24小时内85%有急性呼吸衰竭、78%有休克、30%有昏迷、48%有噬血细胞性淋巴组织细胞增生症;78%接受机械通气、55%接受肾脏替代治疗;30天死亡率为53%。多因素分析显示SOFA评分(OR 1.5,95%CI 1.1-2.1)、症状出现至治疗时间每延迟1天(OR 1.1,95%CI 1.0-1.1)及噬血细胞性淋巴组织细胞增生症(OR 6.4,95%CI 1.1-47.5)与30天死亡独立相关。结论指出该病表现多样、多器官受累严重,多数患者存在免疫缺陷,尽管治疗适当预后仍严重,延迟治疗启动使预后恶化。

要点

  • 纳入两个ICU培养证实的组织胞浆菌病患者40例,30天死亡率为53%。
  • 入ICU 24小时内85%有急性呼吸衰竭、78%有休克、48%有噬血细胞性淋巴组织细胞增生症。
  • 多因素分析:SOFA评分OR 1.5(95%CI 1.1-2.1)与30天死亡独立相关。
  • 症状出现至治疗时间每延迟1天,30天死亡OR 1.1(95%CI 1.0-1.1)。
  • 合并噬血细胞性淋巴组织细胞增生症者30天死亡OR 6.4(95%CI 1.1-47.5)。

适用人群与场景

  • 2014年1月至2022年8月入住法属圭亚那和瓜德罗普两个ICU、培养证实的组织胞浆菌病患者。
  • HIV占58%,其他免疫缺陷占28%,14%未发现基础免疫缺陷。

红旗征与不能漏的情况

  • 入ICU 24小时内85%出现急性呼吸衰竭、78%出现休克、30%出现昏迷、48%出现噬血细胞性淋巴组织细胞增生症。
  • 78%需机械通气、55%需肾脏替代治疗。

研究设计与关键结果

  • 多中心回顾性研究纳入40例患者(65%男性),中位年龄56岁,SAPS II 65。
  • 30天死亡率为53%;多因素分析显示SOFA评分(OR 1.5,95%CI 1.1-2.1)、症状出现至治疗时间每延迟1天(OR 1.1,95%CI 1.0-1.1)和噬血细胞性淋巴组织细胞增生症(OR 6.4,95%CI 1.1-47.5)与30天死亡独立相关。

证据类型、等级与局限

  • 研究类型:多中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为重症组织胞浆菌病表现多样、多器官受累严重,多数患者存在免疫缺陷,尽管治疗适当预后仍严重,延迟治疗启动使预后恶化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To describe clinical and biological features and the outcomes of patients admitted for histoplasmosis in two intensive care units (ICU) in French Guyana and in the French West Indies (Guadeloupe).

METHODS: All patients admitted to these two ICUs for culture-proven histoplasmosis between January 2014 to August 2022 were included in the study. Using univariate and multivariate analysis, we assessed risk factors at ICU admission that were associated with death.

RESULTS: Forty patients were included (65% men). Median age was 56 years and simplified acute physiologic score (SAPS) II was 65. HIV was found in 58%, another immunodeficiency was identified in 28%, and no underlying immunodeficiency could be identified in 14% of patients. Within the first 24 h of ICU admission, 85% of patients had acute respiratory failure, 78% had shock, 30% had coma, and 48% had hemophagocytic lymphohistiocytosis. Mechanical ventilation was instituted in 78% of patients and renal replacement therapy in 55%. The 30-day mortality was 53%. By multivariate analysis, factors independently associated with 30-day mortality were SOFA score (odds ratio [OR] 1.5, 95% confidence interval [CI] [1.1-2.1]), time between symptom onset and treatment per day (OR 1.1, 95% CI 1.0-1.1), and hemophagocytic lymphohistiocytosis (OR 6.4, 95% CI 1.1-47.5).

CONCLUSION: Histoplasmosis requiring ICU admission is a protean disease with multiple and severe organ involvement. Immunodeficiency is found in most patients. The prognosis remains severe despite appropriate treatment and is worsened by late treatment initiation.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Camous L, Surel A, Kallel H, et al. Factors related to mortality in critically ill histoplasmosis: a multicenter retrospective study in Guadeloupe and French Guyana. Ann Intensive Care. 2023. PMID: 37085583. doi:10.1186/s13613-023-01128-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。